Glucose monohydrate - Результати пошуку

novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Європейський Союз - словацька - EMA (European Medicines Agency)

exubera

pfizer limited - insulin human - cukrovka - lieky používané pri cukrovke - exubera je indikovaný na liečbu dospelých pacientov s diabetes mellitus 2. typu notadequately ovládať ústne antidiabetic agentov a vyžadujú inzulínová terapia. exubera je tiež indikovaný na liečbu dospelých pacientov s 1. typu diabetes mellitus, inaddition na dlhé alebo stredne koná podkožného inzulínu, pre ktorých potenciálne výhody ofadding vdýchnutí inzulínu prevyšujú potenciálne bezpečnostné obavy (pozri časť 4.

Європейський Союз - словацька - EMA (European Medicines Agency)

fiasp

novo nordisk a/s - inzulín aspart - cukrovka - drugs used in diabetes, insulins and analogues for injection, fast-acting - liečba diabetes mellitus u dospelých, dospievajúcich a detí vo veku od 1 roka.

Європейський Союз - словацька - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).